{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:23:27Z","timestamp":1782239007797,"version":"3.54.5"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Gastric cancer, characterised by a significant mortality rate, is one of the most prevalent malignant neoplasms globally. Exosomal non-coding RNAs play a key role in gastric carcinogenesis, metastasis and treatment resistance by regulating gene expression, remodelling the tumour microenvironment and mediating drug resistance. In the identification of early gastric cancer, these exosomal non-coding RNA molecules possess significant potential to be developed into biomarkers that do not entail invasive procedures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Our study undertook a comprehensive and profound literature examination in core databases like PubMed, Web of Science, ScienceDirect, Embase, Scopus, and Medline, with the aim of precisely evaluating the potential effectiveness of exosomal miRNAs, lncRNAs, and circRNAs in the diagnosis of gastric cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A sum of 52 studies were incorporated, comprising 164 studies. These studies identified a total of 59 miRNAs, 17 lncRNAs, and 16 circRNAs. For miRNAs, sensitivity was estimated at 0.72 (95% CI, 0.69 - 0.76) and specificity at 0.80 (95% CI, 0.77 - 0.83). For lncRNAs, the sensitivity was 0.86 (95% CI, 0.84 - 0.87) and the specificity was 0.82 (95% CI, 0.80 - 0.83). In the case of circRNAs, the sensitivity and specificity were 0.71 (95% CI, 0.63 - 0.78) and 0.88 (95% CI, 0.81 - 0.93) respectively. The AUC for miRNAs was calculated as 0.83. As for lncRNAs, its AUC was established to be 0.89. Regarding circRNAs, the determined AUC was 0.86.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These results confirm the efficacy of exosomal ncRNAs as powerful biomarkers for the early diagnosis of gastric carcinomas, thereby laying a strong foundation for the advancement of novel diagnostic approaches.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1570020","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:10:49Z","timestamp":1749701449000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic value of exosome non-coding RNAs as non-invasive biomarkers in gastric cancer: a meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Qiumiao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijiang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.21147\/j.issn.1000-9604.2020.06.03","article-title":"Gastric cancer: Epidemiology, risk factors and prevention strategies","volume":"32","author":"Yang","year":"2020","journal-title":"Chin J Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12943-020-01219-0","article-title":"Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance","volume":"19","author":"Yuan","year":"2020","journal-title":"Mol Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-021-01396-6","article-title":"Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications","volume":"20","author":"Tang","year":"2021","journal-title":"Mol Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01715-z","article-title":"Clinical application and detection techniques of liquid biopsy in gastric cancer","volume":"22","author":"Ma","year":"2023","journal-title":"Mol Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.1052069","article-title":"Early detection of gastric cancer via high-resolution terahertz imaging system","volume":"10","author":"Shi","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-019-1001-7","article-title":"Exosomes in gastric cancer: roles, mechanisms, and applications","volume":"18","author":"Fu","year":"2019","journal-title":"Mol Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-018-0935-5","article-title":"Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1\/mTOR pathway","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10147-019-01532-9","article-title":"Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer","volume":"25","author":"Shi","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1021\/acssensors.1c02717","article-title":"DNA nanowire guided-catalyzed hairpin assembly nanoprobe for in situ profiling of circulating extracellular vesicle-associated microRNAs","volume":"7","author":"Zhang","year":"2022","journal-title":"ACS Sens"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.1133","article-title":"Circulating exosomal gastric cancer-associated long noncoding RNA1 as a biomarker for early detection and monitoring progression of gastric cancer: A multiphase study","volume":"155","author":"Guo","year":"2020","journal-title":"JAMA Surg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement","volume":"319","author":"McInnes","year":"2018","journal-title":"Jama"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.cca.2024.117773","article-title":"Exosomal miRNAs from neutrophils act as accurate biomarkers for gastric cancer diagnosis","author":"Yu","year":"2024","journal-title":"Clin Chim Acta"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.34172\/bi.2021.22178","article-title":"Evaluating the presence of deregulated tumoral onco-microRNAs in serum-derived exosomes of gastric cancer patients as noninvasive diagnostic biomarkers","volume":"12","author":"Kahroba","year":"2022","journal-title":"BioImpacts"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22838","article-title":"Exosomal miR-423-5p targets SUFU to promote cancer growth and metastasis and serves as a novel marker for gastric cancer","volume":"57","author":"Yang","year":"2018","journal-title":"Mol Carcinogene"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/7335456","article-title":"Exosome-Encapsulated miR-31, miR-192, and miR-375 Serve as Clinical Biomarkers of Gastric Cancer","volume":"2023","author":"He","year":"2023","journal-title":"J Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/03936155241261390","article-title":"Serum extracellular vesicle-derived miR-21-5p and miR-26a-5p as non-invasive diagnostic potential biomarkers for gastric cancer: A preliminary study","volume":"39","author":"Wang","year":"2024","journal-title":"Int J Biol Markers"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1155\/2022\/5346563","article-title":"Screening of serum exosomal miRNAs as diagnostic biomarkers for gastric cancer using small RNA sequencing","author":"Wang","year":"2022","journal-title":"J Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.683465","article-title":"Evaluation of the diagnostic potential of a plasma exosomal miRNAs panel for gastric cancer","author":"Yang","year":"2021","journal-title":"Front Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202878","article-title":"Exosomes derived from miR-1228 overexpressing bone marrow-mesenchymal stem cells promote growth of gastric cancer cells","volume":"13","author":"Chang","year":"2021","journal-title":"Aging"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16077","article-title":"Circulating exosomal small RNAs are promising non-invasive diagnostic biomarkers for gastric cancer","volume":"24","author":"Ge","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.10.003","article-title":"A serum exosomal microRNA panel as a potential biomarker test for gastric cancer","volume":"493","author":"Wang","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.omtn.2019.07.025","article-title":"miR-374a-5p: A new target for diagnosis and drug resistance therapy in gastric cancer","volume":"18","author":"Ji","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00237","article-title":"Combination of four serum exosomal miRNAs as novel diagnostic biomarkers for early-stage gastric cancer","author":"Tang","year":"2020","journal-title":"Front Genet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1511-6","article-title":"Exosomal transfer of miR-15b-3p enhances tumorigenesis and Malignant transformation through the DYNLT1\/Caspase-3\/Caspase-9 signaling pathway in gastric cancer","volume":"39","author":"Wei","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0792","article-title":"Circulating serum exosomal miR-92a-3p as a novel biomarker for early diagnosis of gastric cancer","volume":"17","author":"Lu","year":"2021","journal-title":"Future Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/srep11251","article-title":"Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis","volume":"5","author":"Zhou","year":"2015","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2021\/e2081","article-title":"Overexpression of serum extracellular vesicle microRNA-215-5p is associated with early tumor recurrence and poor prognosis of gastric cancer","volume":"76","author":"Zhang","year":"2021","journal-title":"Clinics (Sao Paulo Brazil)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0607","article-title":"Six serum-based miRNAs as potential diagnostic biomarkers for gastric cancer","volume":"26","author":"Huang","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cca.2022.03.010","article-title":"Identification of differentially expressed miRNAs derived from serum exosomes associated with gastric cancer by microarray analysis","volume":"531","author":"Ren","year":"2022","journal-title":"Clin Chim Acta"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2023.110653","article-title":"Serum extracellular vesicles with NSD1 and FBXO7 mRNA as novel biomarkers for gastric cancer","volume":"120","author":"Wang","year":"2023","journal-title":"Clin Biochem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2023.04.28.538562","DOI":"10.1101\/2023.04.28.538562","article-title":"Exosomal microRNA signature from plasma-derived extracellular vesicles in gastric cancer","volume":"2023","author":"Rinc\u00f3n-Riveros","year":"2023","journal-title":"bioRxiv"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11373-5","article-title":"Exosomes-mediated transfer of LINC00691 regulates the formation of CAFs and promotes the progression of gastric cancer","volume":"23","author":"Xia","year":"2023","journal-title":"BMC Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S229033","article-title":"Serum exosomal long noncoding RNA Pcsk2-2:1 as a potential novel diagnostic biomarker for gastric cancer","volume":"12","author":"Cai","year":"2019","journal-title":"OncoTargets Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13046-023-02827-6","article-title":"LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement","volume":"42","author":"Zhang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S238706","article-title":"Exosomal long non-coding RNA CEBPA-AS1 inhibits tumor apoptosis and functions as a non-invasive biomarker for diagnosis of gastric cancer","volume":"13","author":"Piao","year":"2020","journal-title":"OncoTargets Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520934297","article-title":"Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer","volume":"48","author":"Zhou","year":"2020","journal-title":"J Int Med Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12708","article-title":"Clinical value of lncRNA CCAT1 in serum extracellular vesicles as a potential biomarker for gastric cancer","volume":"21","author":"Xiao","year":"2021","journal-title":"Oncol Lett"},{"key":"B42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12943-018-0834-9","article-title":"Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer","volume":"17","author":"Lin","year":"2018","journal-title":"Mol Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00432-017-2361-2","article-title":"Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression","volume":"143","author":"Pan","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S253600","article-title":"Plasma exosomal long noncoding RNA lnc-SLC2A12-10:1 as a novel diagnostic biomarker for gastric cancer","volume":"13","author":"Zheng","year":"2020","journal-title":"OncoTargets Ther"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2807-y","article-title":"Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer","volume":"36","author":"Li","year":"2015","journal-title":"Tumor Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0817-x","article-title":"Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer","volume":"17","author":"Zhao","year":"2018","journal-title":"Mol Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.10.047","article-title":"Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer","volume":"501","author":"Li","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B48","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1053\/j.gastro.2023.02.044","article-title":"A liquid biopsy signature for the early detection of gastric cancer in patients","volume":"165","author":"Guo","year":"2023","journal-title":"Gastroenterology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0803-6","article-title":"Long non-coding RNA UFC1 promotes gastric cancer progression by regulating miR-498\/Lin28b","volume":"37","author":"Zhang","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00873-w","article-title":"Expression and mechanism of exosome-mediated A FOXM1 related long noncoding RNA in gastric cancer","volume":"19","author":"Zhang","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23323","article-title":"Identification of serum exosomal lncRNA MIAT as a novel diagnostic and prognostic biomarker for gastric cancer","volume":"34","author":"Xu","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03853-2","article-title":"Circular RNA 0001789 sponges miR-140-3p and regulates PAK2 to promote the progression of gastric cancer","volume":"21","author":"You","year":"2023","journal-title":"J Trans Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.962831","article-title":"Expression and clinical value of circRNAs in serum extracellular vesicles for gastric cancer","volume":"12","author":"Xiao","year":"2022","journal-title":"Front Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2022.1610446","article-title":"Plasma exosomal hsa_circ_0015286 as a potential diagnostic and prognostic biomarker for gastric cancer","volume":"28","author":"Zheng","year":"2022","journal-title":"Pathol Oncol Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2023.2206984","article-title":"CircRNA CDR1as: a novel diagnostic and prognostic biomarker for gastric cancer","volume":"28","author":"Li","year":"2023","journal-title":"Biomarkers"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0888-8","article-title":"CircRNA microarray profiling identifies a novel circulating biomarker for detection of gastric cancer","volume":"17","author":"Tang","year":"2018","journal-title":"Mol Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02976-w","article-title":"Exosomal hsa_circ_000200 as a potential biomarker and metastasis enhancer of gastric cancer via miR-4659a\/b-3p\/HBEGF axis","volume":"23","author":"Huang","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i22.3482","article-title":"Plasma exosomal hsa_circ_0079439 as a novel biomarker for early detection of gastric cancer","volume":"29","author":"Li","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152763","article-title":"Clinical significance of hsa_circ_0000419 in gastric cancer screening and prognosis estimation","volume":"216","author":"Tao","year":"2020","journal-title":"Pathol Res Pract"},{"key":"B60","article-title":"Expression of plasma exosomal circLPAR1 in patients with gastric cancer and its clinical application value","volume":"13","author":"Yang","year":"2023","journal-title":"Am J Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.tranon.2024.101969","article-title":"Exosomal circ50547 as a potential marker and promotor of gastric cancer progression via miR-217\/HNF1B axis","author":"Zang","year":"2024","journal-title":"Trans Oncol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-019-00716-y","article-title":"Hsa_circ_0065149 is an indicator for early gastric cancer screening and prognosis prediction","volume":"26","author":"Shao","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2021.1878327","article-title":"Circular RNA ITCH suppresses metastasis of gastric cancer via regulating miR-199a-5p\/Klotho axis","volume":"20","author":"Wang","year":"2021","journal-title":"Cell Cycle"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2022.2087280","article-title":"circFCHO2 promotes gastric cancer progression by activating the JAK1\/STAT3 pathway via sponging miR-194-5p","volume":"21","author":"Zhang","year":"2022","journal-title":"Cell Cycle"},{"key":"B65","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/labmed\/lmab062","article-title":"Diagnostic value of circular RNA hsa_circ_0002874 expression in peripheral blood of patients with gastric cancer","volume":"53","author":"Sun","year":"2022","journal-title":"Lab Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i12.1187","article-title":"Epidemiology of stomach cancer","volume":"28","author":"Ilic","year":"2022","journal-title":"World J Gastroenterol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41419-022-05350-2","article-title":"Liquid biopsy in gastric cancer: predictive and prognostic biomarkers","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216127","article-title":"Burden of gastrointestinal cancers in China from 1990 to 2019 and projection through 2029","volume":"560","author":"Chen","year":"2023","journal-title":"Cancer Lett"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124463","article-title":"Extracellular vesicles in cancer metastasis: potential as therapeutic targets and materials","volume":"21","author":"Kogure","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.canlet.2021.02.011","article-title":"Exosome-mediated delivery of RNA and DNA for gene therapy","volume":"505","author":"Munagala","year":"2021","journal-title":"Cancer Lett"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e12356","DOI":"10.1002\/jev2.12356","article-title":"Identification of the SNARE complex that mediates the fusion of multivesicular bodies with the plasma membrane in exosome secretion","volume":"12","author":"Liu","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B73","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-020-00261-0","article-title":"Exosomes: key players in cancer and potential therapeutic strategy","volume":"5","author":"Dai","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.04.012","article-title":"Tumor-derived exosomes: Nanovesicles made by cancer cells to promote cancer metastasis","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm Sin B"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1570020\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:10:50Z","timestamp":1749701450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1570020\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":74,"alternative-id":["10.3389\/fonc.2025.1570020"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1570020","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"article-number":"1570020"}}